Identification of Single Nucleotide Non-coding Driver Mutations in Cancer

Area of Science:

• Genomics
• Cancer Biology
• Molecular Biology

Background:

• Whole-genome sequencing reveals millions of somatic variants in tumors, predominantly in non-coding regions.
• These non-coding variants may influence gene regulation, but their functional roles are largely unknown.
• Distinguishing driver from passenger variants and understanding regulatory element function are key challenges.

Purpose of the Study:

• To provide an overview of computational approaches for prioritizing somatic non-coding variants.
• To present experimental methods for the functional validation and characterization of these variants.

Main Methods:

• In silico prioritization strategies based on mutational burden and location in regulatory elements.
• Experimental validation combining physical binding assays (e.g., ChIP) and regulatory activity assays (e.g., luciferase reporter assays).

Main Results:

• Discusses the integration of computational predictions with experimental validation for non-coding variants.
• Highlights the importance of a multi-modal approach to assess variant function.

Conclusions:

• Systematic characterization of somatic non-coding variants is crucial for understanding cancer driver mutations.
• Combining in silico prioritization with robust experimental validation is essential for functional genomics research in cancer.